IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA 78repository.unair.ac.id/89583/3/TKKli. 72-19 Ang p daftar... · 2019. 10. 21. · practical clinical definition of epilepsy. Epilepsia. 55:

78

DAFTAR PUSTAKA

Abd El-Aziz, S.E. 2012. Antinuclear antibodies and glutamic acid decarboxylase

antibodies in children with refractory epilepsy. Egyptian. Pediatric.

Association. Gazette. 46–51.

Ali, C., S. Ayse., Y. Deniz., D, Vehbi., O. Secil and H. Tugbna. Prevalence of

some risk factors in childhood with epilepsy compared to their controls.

Seizure. 2007.16: 338-344.

Andrianti, P. T. dan P. F. Gunawan. 2016. Profil Epilepsi Anak dan Keberhasilan

Pengobatannya di RSUD Dr. Soetomo Tahun 2013. Sari. Pediatri. 18: 34-39.

Aneja, S. and P. Jain. 2014. Refractory Epilepsy in Children. The. Ind. Jour. of.

Ped. 81: 1063-1072.

Baekkeskov, S., H.J. Aanstoot and S. Christgau. 1990. Identification of the 64K

autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme

glutamic acid decarboxylase. Nature. 347: 151-156.

Beleza, P. 2009. Refractory epilepsy: a clinically oriented review. Eur. Neuro. 62:

65-71.

Bien, C.G. and I. E. Scheffer. 2011. Autoantibodies and epilepsy. Epilepsia. 52

Suppl 3: 18-22.

Brenner, T., G.J. Sills dan Y. Hart. 2013. Prevalence of neurologic autoantibodies

in cohorts of patients with new and established epilepsy. Epilepsia. 54. 1028-

1035.

Ceyhan, D. A., S. Elibirlik., A. Koksal., M. Özturk., Y. Altunkaynak., S. Baybas.,

and A. Dirican. 2016. Evaluation of Glutamic Acid Decarboxylase Antibody

Levels in Patients with Juvenile Myoclonic Epilepsy and Mesial Temporal

Lobe Epilepsy with Hippocampal Sclerosis. Noro. Psikiyatr. Ars. 53. 253-256

Cho, C.H. 2013. New mechanism for glutamate hypothesis in epilepsy. Front Cell

Neurosci. 7:233-250

Choi, D.W. 1993. Nitric oxide: foe or friend to the injured brain? Proc. Natl.

Acad. Sci USA. 90. 9741-9743.

Christensen, J., M. J. Kjeldsen., H. Andersen., M. L. Friis and P. Sidenius. 2005.

Gender differences in epilepsy. Epilepsia. 46. 956-960.

IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA

TESIS PERBANDINGAN KADAR AUTOANTIBODI….. Novi Dwi Anggraini

79

Christgau, S., H. Schierbeck and H.J. Aanstoot. 1991. Pancreatic beta cells

express two autoantigenic forms of glutamic acid decarboxylase, a 65-kDa

hydrophilic form and a 64-kDa amphiphilic form which can be both

membrane-bound and soluble. J. Biol. Chem. 266: 21257-21264.

Çoban, A., E. Ekizoğlu and E. Tüzün. 2013. Epilepsy and Autoimmunity. Journal.

of. the. Turkish. Chapter of ILAE. 19: 39-47.

Coulter, D. A. and T. Eid. 2012. Astrocytic regulation of glutamate homeostasis

in epilepsy. Glia. 60. 1215-26.

Crotti, C and C. Selmi. 2014. Glutamic Acid Decarboxylase Antibody, Italy. 630-

658.

Dash, P.,K., S. A. Mach and A. N. Moore. 2001. Enhanced neurogenesis in the

rodent hippocampus following traumatic brain injury. J. Neurosci. Res. 63.

313-319.

De Deyn PP and R. L. Macdonald. 1990. Guanidino compounds that are increased

in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine

responses on mouse neurons in cell culture. Ann. Neurol. 28. 627-633.

Del-bel EA, P.R. Oliveira., J. A. Oliviera., P. K. Mishra., P. C. Jobe., and N.

Garcia-Cairasco. 1997. Anticonvulsant and proconvulsant roles of nitric

oxide in experimental epilepsy models. Braz. J. Med. Biol. Res. 30. 971-979.

Dinkel K., H. M. Meinck., K. M. Jury., W. Karges and W. Richter. 1998.

Inhibition of gamma-aminobutyric acid synthesis by glutamic acid

decarboxylase autoantibodies in stiff-man syndrome. Ann. Neurol. 44: 194-

201.

Dubey, D., A. Alqallaf., R. Hays., M. Freeman., K. Chen., K. Ding., M. Agostini.,

S. Vernino. 2017. Neurological Autoantibody Prevalence in Epilepsy of

Unknown Etiology. JAMA Neurol. 74: 397-402.

Dubey, D., K. Blackburn., B. Greenberg., O. Stuve and S. Vernino. 2016.

Diagnostic and therapeutic strategies for management of autoimmune

encephalopathies. Expert. Rev. Neurother. 16: 937-949.

Eeg-Olofsson, O. 2003. Virological and immunological aspects of seizure

disorders. Brain. Dev. 25. 9-13.



80

Eid, T., M. J. Thomas., D. D. Spencer., E. Ruden-Pran., J. C. Lai., G. V.

Malthankar., J. H. Kim., N. C. Danbolt., O. P. Ottersen and N. C. de

Lanerolle. 2004. Loss of glutamine synthetase in the human epileptogenic

hippocampus: possible mechanism for raised extracellular glutamate in

mesial temporal lobe epilepsy. Lancet, 363, 28-37. .

Engelborghs, S., R. D'hooge and P. P. De Deyn. 2000. Pathophysiology of

epilepsy. Acta Neurol Belg. 100: 201-13.

Errichiello, L., G. Perruolo., A. Pascarella., P. Formisano., C. Minetti., S. Striano.,

F. Zara and P. Striano 2009. Autoantibodies to glutamic acid decarboxylase

(GAD) in focal and generalized epilepsy: A study on 233 patients. J.

Neuroimmunol. 211. 120-123.

Errichiello, L., S. Striano., F. Zara and P. Striano. 2011. Temporal lobe epilepsy

and anti glutamic acid decarboxylase autoimmunity. Neurol. Sci. 32. 547-

550.

Falip, M., M. Carreno., J. Miro., A. Saiz., V. Villanueva., A. Quilez., A. Molins.,

I. Barcelo., A. Sierra and F. Graus. 2012. Prevalence and immunological

spectrum of temporal lobe epilepsy with glutamic acid decarboxylase

antibodies. Eur. J. Neurol. 19. 827-833.

Faulkner-Jones, B. E., D. S. Cram., J. Kun and L. C. Harrison. 1993. Localization

and quantitation of expression of two glutamate decarboxylase genes in

pancreatic beta-cells and other peripheral tissues of mouse and rat.

Endocrinology. 133: 2962-2972.

Fenalti, G., R. H. Law., A. M. Buckle., C. Langendorf., K. Tuck., C. J. Rosado.,

N. G. Faux., K. Mahmood., C. S. Hampe., J. P. Banga., M. Wilce., J.

Schmidberger., J. Rossjohn., O. El-Kabbani., R. N. Pike., A. I. Smith., I. R.

Mackay., M. J. Rowley and J. C. Whisstock. 2007. GABA production by

glutamic acid decarboxylase is regulated by a dynamic catalytic loop. Nat.

Struct. Mol. Biol. 14: 280-286.

Fisher, R. S., C. Acevedo and A. Arzimanoglou. 2014. ILAE official report: a

practical clinical definition of epilepsy. Epilepsia. 55: 475-482.

Fujikawa, D.G. 2015. The role of excitotoxic programmed necrosis in acute brain

injury. Comput. Struct. Biotechnol. J. 13: 212-221.



81

Gaillard, W.D., C. Chiron., J. H. Cross., A. S. Harvey., R. Kuzniecky., L. Hertz-

pannier and L. G. Vezina. 2009. Guidelines for imaging infants and children

with recent-onset epilepsy. Epilepsia. 50: 2147-53.

Gasparini, S., E. Ferlazzo., E. Beghi., V. Sofia., L. Mumoli., A. Labate., V.

Cianci., D. Fatuzzo., M. A. Bellavia., L. Arcudi., E. Russo., G. De Sarro., A.

Gambardella and U. Aguglia. 2015. Epilepsy associated with Leukoaraiosis

mainly affects temporal lobe: a casual or causal relationship? Epilepsy. Res.

109: 1-8.

Gayatri, N. A., C. D. Ferrie and H. Cross. 2007. Corticosteroids including ACTH

for childhood epilepsy other than epileptic spasms. Cochrane. Database. Syst.

Rev. Cd005222.

Geng, J., J. Dong., Y. Li., H. Ni., K. Jiang., L. L. Shi and G. Wang. 2011.

Intravenous immunoglobulins for epilepsy. Cochrane. Database. Syst. Rev.

Cd008557.

Gibson, L.M., M. F. Hanby., S. M. Al-Bachari., L. M. Parkes., S. M. Allan and H.

C. Emsley. 2014. Late-onset epilepsy and occult cerebrovascular disease. J.

Cereb. Blood. Flow. Metab. 34: 564-570.

Giometto, B., P. Nicolao., M. Macucci., B. Tavolato., R. Foxon, and G. F.

Bottazzo. 1998. Temporal-lobe epilepsy associated with glutamic-acid-

decarboxylase autoantibodies. Lancet. 352: 457.

Glauser, T., E. Ben-Menachem., B. Bourgeois., A. Cnaan., D. Chadwick., C.

Guerreiro., R. Kalviainen., R. Mattson., E. Perucca and T. Tomson. 2006.

ILAE treatment guidelines: evidence-based analysis of antiepileptic drug

efficacy and effectiveness as initial monotherapy for epileptic seizures and

syndromes. Epilepsia. 47: 1094-1120.

Glauser, T., G. Kluger., R. Sachdeo., G. Krauss., C. Perdomo and S. Arroyo.

2008. Rufinamide for generalized seizures associated with Lennox-Gastaut

syndrome. Neurology. 70: 1950-1958.

Gonzalez-Martinez, J. A., A. Gupta and P. Kotagal. 2005. Hemispherectomy for

catastrophic epilepsy in infants. Epilepsi. 46: 1518-25.

Graber, K. D., and A. Prince. 1999. Tetrodotoxin prevents posttraumatic

epileptogenesis in rats. Ann. Neurol. 46. 234-242.



82

Had-Aissouni, L. 2012. Toward a new role for plasma membrane sodium-

dependent glutamate transporters of astrocytes: maintenance of antioxidant

defenses beyond extracellular glutamate clearance. Amino. Acids. 42. 181-

197.

Hardingham, G. E., and H. Bading. 2002. Coupling of extrasynaptic NMDA

receptors to a CREB shut-off pathway is developmentally regulated.

Biochim. Biophys. Acta. 1600: 148-153.

Holmseth, S., Y. Zhou., V. V. Follin-Arbelet., K. P. Lehre., D. E. Bergles and N.

C. Danbolt. 2012. Specificity controls for immunocytochemistry: the antigen

preadsorption test can lead to inaccurate assessment of antibody specificity. J.

Histochem. Cytochem. 60: 174-187.

Hussain, S. and R. Sankar. 2011. Pharmacologic treatment of intractable epilepsy

in children: a syndrome-based approach. Semin. Pediatr. Neurol. 18: 171-

178.

Institute Of Medicine Forum On Microbial. 2004. The National Academies

Collection: Reports funded by National Institutes of Health. In: Knobler, S.

L., S. O'connor., S. M. Lemon and M. Najafi (eds.) The Infectious Etiology of

Chronic Diseases: Defining the Relationship, Enhancing the Research, and

Mitigating the Effects: Workshop Summary. Washington (DC): National

Academies Press (US)

Irani, S. R., S. Alexander., P. Waters., K. A. Kleopa., P. Pettingill., L. Zuliani., E.

Peles., C. Buckley., B. Lang and A. Vincent. 2010. Antibodies to Kv1

potassium channel-complex proteins leucine-rich, glioma inactivated 1

protein and contactin-associated protein-2 in limbic encephalitis, Morvan's

syndrome and acquired neuromyotonia. Brain. 133: 2734-2748.

Ishida, K., H. Mitoma., Y. Wada., T. Oka., J. Shibahara., Y. Saito., S. Murayama

and H. Mizusawa. 2007. Selective loss of Purkinje cells in a patient with

anti‐glutamic acid decarboxylase antibody‐associated cerebellar ataxia. J.

Neurol. Neurosurg. Psychiatry. 78: 190-192.

Kanter, I. C., H. B. Huttner., D. Staykov., T. Biermann., T. Struffert., F. Kerling.,

M. J. Hilz., P. D. Schellinger., S. Schwab and J. Bardutzky. 2008.

Cyclophosphamide for anti-GAD antibody-positive refractory status

epilepticus. Epilepsia. 49: 914-920.



83

Kash, S. F., R. S. Johnson., L. H. Tecott., J. L. Noebels., R. D. Mayfield., D.

Hanahan and S. Baekkeskov. 1997. Epilepsy in mice deficient in the 65-kDa

isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. USA. 94:

14060-14065.

Ko, T. S., and G. L. Holmes. 1999. EEG and clinical predictors of medically

intractable childhood epilepsy. Clin. Neurophysiol. 110: 1245-1251.

Kossoff, E. H. 2011. Intractable childhood epilepsy: choosing between the

treatments. Semin. Pediatr. Neurol. 18: 145-149.

Kotagal, P. 2011. Neurostimulation: vagus nerve stimulation and beyond. Semin.

Pediatr. Neurol. 18: 186-194.

Kwan, P., A. Arzimanoglou., A. T. Berg., M. J. Brodie., W. Allen hauser., G.

Mathern., S. L. Moshe., E. Perucca., S. Wiebe and J. French. 2010. Definition

of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the

ILAE Commission on Therapeutic Strategies. Epilepsia. 51: 1069-1077.

Kwan, P., G. J. Sills., K. Kelly., E. Butler and M. J. Brodie. 2000. Glutamic acid

decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot

study. Epilepsy. Res. 42: 191-195.

Lancaster, E., E. Martinez-Hernandez and J. Dalmau. 2011. Encephalitis and

antibodies to synaptic and neuronal cell surface proteins. Neurology. 77: 179-

189.

Levite, M and Y. Ganor. 2008. Autoantibodies to glutamate receptors can damage

the brain in epilepsy, systemic lupus erythematosus and encephalitis. Expert.

Rev. Neurother. 8: 1141-1160.

Levy, R. G., P. N. Cooper and P. Giri. 2012. Ketogenic diet and other dietary

treatments for epilepsy. Cochrane. Database. Syst. Rev. Cd001903.

Liimatainen, S. P. M., L. Sabater., M. Fallah., E. Kharazmi., A. M. Haapala., P.

Dastidar., M. Knip., A. Saiz and J. Peltola. 2010. Clinical significance of

glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia.

51(5): 760–767.

Lilleker, J. B., V. Biswas and R. Mohanraj. 2014. Glutamic acid decarboxylase

(GAD) antibodies in epilepsy: diagnostic yield and therapeutic implications.

Seizure. 23: 598-602.

Luft, S. R., A. Kaelin-Lang and T. K. Hauser. 2002. Modulation of rodent cortical

motor excitability by somatosensory input. Exp. Brain. Res. 142: 562-569.



84

Mäkelä, K. M., A. Hietaharju., A. Brander and J. Peltola. 2018. Clinical

Management of Epilepsy With Glutamic Acid Decarboxylase Antibody

Positivity: The Interplay Between Immunotherapy and Anti-epileptic Drugs.

Front. Neurol. 9: 579.

Mandolesi, G., A. Musella., A. Gentile., G. Grasselli., N. Haji., H. Sepman., D.

Fresegna., S. Bullitta., F. De vito., G. Musumeci., C. Di sanza., P, strata and

D. Centonze. 2013. Interleukin-1beta alters glutamate transmission at

purkinje cell synapses in a mouse model of multiple sclerosis. J. Neurosci.

33: 12105-12121.

Manto, M. U., M. A. Laute., M. Aguera., V. Rogemond., M. Pandolfo and J.

Honnorat. 2007. Effects of anti-glutamic acid decarboxylase antibodies

associated with neurological diseases. Ann. Neurol. 61. 544-551.

Mata, S., G. C. Muscas., I. Naldi., E. Rosati., S. Paladini., B. Cruciatti., F. Bisulli.,

M. Paganini., G. Mazzi., S. Sorbi and P. Tinuper. 2008. Non-paraneoplastic

limbic encephalitis associated with anti-glutamic acid decarboxylase

antibodies. J. Neuroimmunol. 199: 155-159.

Mathews, G. C. 2007. The dual roles of GABA in seizures and epilepsy generate

more excitement. Epilepsy. Curr. 7: 28-30.

Mc Hugh, J. C. and N. Delanty. 2008. Epidemiology and classification of

epilepsy: gender comparisons. Int. Rev. Neurobiol. 83: 11-26.

Mckenna, M. C. 2007. The glutamate-glutamine cycle is not stoichiometric: fates

of glutamate in brain. J. Neurosci. Res. 85: 3347-3358.

Mcknight, K., Y. Jiang., Y. Hart., A. Cavey., S. Wroe., M. Blank., Y. Shoenfeld.,

A. Vincent., J. Palace and B. Lang. 2005. Serum antibodies in epilepsy and

seizure-associated disorders. Neurology. 65: 1730-1736.

Menon, B and S. D. Shorvon. 2009. Ischaemic stroke in adults and epilepsy.

Epilepsy. Res. 87: 1-11.

Mitoma, H. M. M. and C. S. Hampe. 2017. Immune-mediated cerebellar ataxias:

from bench to bedside. Cerebellum & Ataxias. vol. 4: 1.

Molyneux, M. E. 2000. Impact of malaria on the brain and its prevention. Lancet.

355. 671-672.

Morais, N. M., J. Ranzan and R. S. Riesgo. 2013. Predictors of Epilepsy in

Children With Cerebrovascular Disease. J. Child. Neurol. 28: 1387-1391.



85

Morris, G. L., D. Gloss., J. Buchhalter., K. J. Mack., K. Nickels and C. Harden.

2013. Evidence-based guideline update: vagus nerve stimulation for the

treatment of epilepsy: report of the Guideline Development Subcommittee of

the American Academy of Neurology. Neurology. 81: 1453-1459.

Niehusmann, P., J. Dalmau., C. Rudlowski., A. Vincent., C. E. Elger., J. E. Rossi

and C. G. Bien. 2009. Diagnostic value of N-methyl-D-aspartate receptor

antibodies in women with new-onset epilepsy. Arch. Neurol. 66: 458-464.

Nitkunan, A., S. Lanfranconi., R. A. Charlton, T. R. Barrick and H. S. Markus.

2011. Brain atrophy and cerebral small vessel disease: a prospective follow-

up study. Stroke. 42. 133-138.

Nortje,J and D. K. Menon. 2004. Traumatic brain injury: physiology,

mechanisms, and outcome. Curr. Opin. Neurol. 17: 711-718.

Olmos, G. 2014. Tumor Necrosis Factor Alpha: A Link between

Neuroinflammation and Excitotoxicity. Mediators. of. Inflammation. 2014:

12.

Oulad Ben Taib, N., M. A. Laute., M. Pandolfo and M. U. Manto. 2004.

Interaction between repetitive stimulation of the sciatic nerve and functional

ablation of cerebellar nucleus interpositus in the rat. Cerebellum. 3. 21-26.

Pal, D. K., A. W. Pong and W. K Chung. 2010. Genetic evaluation and counseling

for epilepsy. Nat. Rev. Neurol. 6: 445-453.

Pantoni, L. 2010. Cerebral small vessel disease: from pathogenesis and clinical

characteristics to therapeutic challenges. Lancet. Neurol. 9. 689-701.

Peltola, J., P. Kulmala., J. Isojarvi., A. Saiz., K. Latvala., J. Palmio., K. Savola.,

M. Knip., T. Keranen and F. Graus. 2000. Autoantibodies to glutamic acid

decarboxylase in patients with therapy-resistant epilepsy. Neurology. 55: 46-

50.

Perez, E. L., F. Lauritzen., Y. Wang., T. S. Lee., D. Kang., H. P. Zaveri., F. A.

Chaudhry., O. P. Ottersen., L. H. Bergersen and T. Eid. 2012. Evidence for

astrocytes as a potential source of the glutamate excess in temporal lobe

epilepsy. Neurobiol. Dis. 47. 331-337.

Petroff, O. A. 2002. GABA and glutamate in the human brain. Neuroscientist. 8.

562-573.



86

Piccolo, G., E. Tavazzi., T. Cavallaro., A. Romani., R. Scelsi and G Martino.

2010. Clinico-pathological findings in a patient with progressive cerebellar

ataxia, autoimmune polyendocrine syndrome, hepatocellular carcinoma and

anti-GAD autoantibodies. J. Neurol. Sci. 290: 148-149.

Poonam, N. B., H. W. Allen. 2007. Epilepsy. In: Engel, J., T. A. Pedley (ed.)

Epilepsy: a comprehensive textbook. Edisi kedua ed. Philadelphia Lippincott

Williams & Wilkins.

Quek, A. M. L., J. W. Britton., A. Mckeon., E. So., V. A. Lennon., C. Shin., C. J.

Klein., R. E. Watson., A. L. Kotsenas., T. D. Lagerlund., G. D. Cascino., G.

A. Worrell., E. C. Wirrell., K. C. Nickels., A. J. Aksamit., K. H. Noe and S. J.

Pittock. 2012. Autoimmune Epilepsy: Clinical Characteristics and Response

to Immunotherapy. Arch. Neurol. 69: 582-593.

Ramanathan, S., A. Bleasel., J. Parratt., C. Orr., R. C. Dale., A. Vincent and V. S.

Fung. 2014. Characterisation of a syndrome of autoimmune adult onset focal

epilepsy and encephalitis. J. Clin. Neurosci. 21: 1169-1175.

Ramzi., Y. Soenarto., Sunartini., M. Hakimi. 2008. Prognostic factors of

refractory epilepsy in children. Paediatr. Indones. Volume 48: 269-273.

Riviello, J. J., JR., S. Ashwal., D. Hirtz., T. GlauseR., K. Ballaban-gil., K. Kelley.,

L. D. Morton., S. Phillips., E. Sloan and S. Shinnar. 2006. Practice parameter:

diagnostic assessment of the child with status epilepticus (an evidence-based

review): report of the Quality Standards Subcommittee of the American

Academy of Neurology and the Practice Committee of the Child Neurology

Society. Neurology. 67: 1542-1550.

Rosenow, F. and H. Luders. 2001. Presurgical evaluation of epilepsy. Brain. 124:

1683-1700.

Sahoo, P., K. I. Mathai., G. V. Ramdas and M. N. Swamy. 2007. The

pathophysiology of post-traumatic epilepsy. Ind. J. Neurotrauma. 4. 11–14.

Santhakumar, V., A. D. Ratzliff., J. Jeng., Z. Toth and I. Soltesz. 2001. Long-term

hyperexcitability in the hippocampus after experimental head trauma. Ann.

Neurol. 50. 708-717.

Scheffer, I. E., S. Berkovic., G. Capovilla., M. B. Connolly., J. French., L.

Guilhoto., E. Hirsch., S. Jain., G. W. Mathern., S. L. Moshé., D. R. Nordli.,

E. Perucca., T. Tomson., S. Wiebe., Y. H. Zhang and S. M. Zuberi. 2017.



87

ILAE classification of the epilepsies: Position paper of the ILAE Commission

for Classification and Terminology. Epilepsia. 58: 512-521.

Schmidli, R. S., P. G. Colman., E. Bonifacio., G. F. Bottazzo and L. C. Harrison .

1994. High level of concordance between assays for glutamic acid

decarboxylase antibodies. The First International Glutamic Acid

Decarboxylase Antibody Workshop. Diabetes. 43: 1005-1009.

Schwartzkroin, P. A., S. C. Baraban and D. W. Hochman. 1998. Osmolarity, ionic

flux, and changes in brain excitability. Epilepsy. Res. 32: 275-285.

Seissler, J., J. Amann., L. Mauch., H. Haubruck., S. Wolfahrt., S. Bieg., W.

Richter., R. Holl., E. Heinze and W. Northemann. 1993. Prevalence of

autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in

insulin-dependent diabetes mellitus. J. Clin. Invest. 92: 1394-1399.

Shinnar, S and J. M. Pellock. 2002. Update on the epidemiology and prognosis of

pediatric epilepsy. J. Child. Neurol. 17. Suppl 1: S4-17.

Silverstein, F. S., B. Naik and J. Simpson. 1991. Hypoxia-ischemia stimulates

hippocampal glutamate efflux in perinatal rat brain: an in vivo microdialysis

study. Pediatr. Res. 30. 587-590.

Spencer, S and L. Huh. 2008. Outcomes of epilepsy surgery in adults and

children. Lancet. Neuro. 7: 525-537.

Stafstrom, C. E. 1998. Back to Basics: The Pathophysiology of Epileptic Seizures:

A Primer For Pediatricians. Ped. in. Rev. 19: 342-351.

Stagg, C. J., B. Lang and J. G. Best., K. McKnight., A. Cavey., H. Johansen-berg.,

A. Vincent and J. Palace. 2010. Autoantibodies to glutamic acid

decarboxylase in patients with epilepsy are associated with low cortical

GABA levels. Epilepsia. 51: 1898-1901.

Suwarba, I. 2011. Insidens dan Karakteristik Klinis Epilepsi pada Anak. Sari.

Pediatri. vol. 13. 123-128.

Suzumura, A. 2013. Neuron-microglia interaction in neuroinflammation. Curr.

Protein. Pept. Sci. 14: 16-20.

Temkin, N. R., S. D. Jarell and G. D. Anderson. 2001. Antiepileptogenic agents:

how close are we?. Drugs. 61. 1045-1055.



88

Thiha, A and F. Ibrahim. 2015. A Colorimetric Enzyme-Linked Immunosorbent

Assay (ELISA) Detection Platform for a Point-of-Care Dengue Detection

System on a Lab-on-Compact-Disc. Sensors (Basel). 15: 11431-11441.

Tian, G. F., H. Azmi., T. Takano., Q. Xu., W. Peng., J. Lin., N. A. Oberheim., N.

Lou., R. Zielke., J. Kang and M. Nedergaard. 2005. An astrocytic basis of

epilepsy. Nat. Med. 11. 973-981.

Tjandrajani, A. 2012. Karakteristik kasus epilepsi di Rumah Sakit Anak dan

Bunda Harapan Kita pada tahun 2008-2010. Sari. Pediatri. 14. 143-146.

Topbas, M., S. Ozgun., M. F. Sonmez., A. Aksoy, G. Can., A. Yavuzyilmaz and

E. Can. 2012. Epilepsy prevalence in the 0-17 age group in trabzon, Turkey.

Iran. J. Pediatr. 22. 344-350.

Triono, A dan E. Herini. 2014. Faktor prognostik kegagalan terapi epilepsi pada

anak dengan monoterapi. Sari. Pediatri. 16: 248-253.

Vannucci, R. C., J. R. Connor., D. T. Mauger., C. Palmer., M. B. Smith., J.

Towfighi and S. J. Vannucci. 1999. Rat model of perinatal hypoxic-ischemic

brain damage. J. Neurosci. Res. 55: 158-163.

Verellen, R. M. and J. E. Cavazos. 2010. Post-traumatic epilepsy: an overview.

Therapy. 7: 527-531.

Veri, K., O. Uibo., T. Talvik., I. Talvik., K. Metskula., A. Napa., U. Vaher., E.

Oiglane-slik., R. Rein., A. Kolk., A. Traat and R. Uibo. 2013. Newly-

diagnosed pediatric epilepsy is associated with elevated autoantibodies to

glutamic acid decarboxylase but not cardiolipin. Epilepsy. Res. 105: 86-91.

Vincent A, S. R. Irani and B. Lang. 2010. The growing recognition of

immunotherapy-responsive seizure disorders with autoantibodies to specific

neuronal proteins. Curr. Opin. Neuro. 23: 144-150.

Vincent A, I. S. and B. Lang. 2011. Potentially Pathogenic Autoantibodies

Associated with Epilepsy and Encephalitis in Children and Adults. Epilepsia.

52.(Suppl. 8): 8–11.

Walker, M.C., H. S White and J. W. Sander. 2002. Disease modification in partial

epilepsy. Brain. 125: 1937-1950.

Wall, M. J. 2003. Endogenous nitric oxide modulates GABAergic transmission to

granule cells in adult rat cerebellum. Eur. J. Neurosci. 18. 869-878.



89

Welsh, F. A,, R. C. Vannucci and J. B. Brierley. 1982. Columnar alterations of

NADH fluorescence during hypoxia-ischemia in immature rat brain. J. Cereb.

Blood. Flow. Metab. 2: 221-228.

World Health Organization. 1976. The enzyme-linked immunosorbent assay

(ELISA). Bull World Health Organ. 54: 129-139.

Wiest, R., F. Von bredow., K. Schindler., B. Schauble., J. Slotboom., C.

Brekenfeld., L. Remonda., G.schroth and C. Ozdoba. 2006. Detection of

regional blood perfusion changes in epileptic seizures with dynamic brain

perfusion CT--a pilot study. Epilepsy. Res. 72: 102-110.

Wong, W. T., M. Wang dan W. Li. 2011. Regulation of Microglia by Ionotropic

Glutamatergic and GABAergic Neurotransmission. Neuron. Glia. Biol. 7: 41-

46.

Woo, D. H., K. S. Han., J. W. Shim., B. E. Yoon., E. Kim., J. Y. Bae., S.J. Oh.,

E.M. Hwang., A. D. Marmorstein., Y. C. Bae., J. Y. Park and C. J. Lee.

2012. TREK-1 and Best1 channels mediate fast and slow glutamate release in

astrocytes upon GPCR activation. Cell. 151: 25-40.

Yuste, J. E., E. Tarragon., C. M. Campuzano and F. Ros-Bernal. 2015.

Implications of glial nitric oxide in neurodegenerative diseases. Front. Cell.

Neurosci. 9:11-15.



COVERPERSETUJUANPERNYATAANPENGESAHANPENETAPAN PANITIA PENGUJIKATA PENGANTARUCAPAN TERIMA KASIHRINGKASANSUMMARYABSTRAKABSTRACTDAFTAR ISIDAFTAR GAMBARDAFTAR TABELDAFTAR LAMPIRANDAFTAR SINGKATANBAB 1 PendahuluanBAB 2 Tinjauan KepustakaanBAB 3 Kerangka KonseptualBAB 4 Metodologi PenelitianBAB 5 Hasil Penelitian revisiBAB 6 PembahasanBAB 7 KesimpulanDAFTAR PUSTAKALAMPIRAN

Documents

IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA 78repository.unair.ac.id/89583/3/TKKli. 72-19 Ang p daftar... · 2019. 10. 21. · practical clinical definition of epilepsy. Epilepsia. 55: